ERICH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.430100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.707900E-02
Normal-vs-Stage2
9.612100E-02
Normal-vs-Stage3
3.133600E-01
Normal-vs-Stage4
7.377200E-01
Stage1-vs-Stage2
3.392000E-01
Stage1-vs-Stage3
6.568600E-01
Stage1-vs-Stage4
3.676200E-02
Stage2-vs-Stage3
7.671400E-01
Stage2-vs-Stage4
1.872170E-01
Stage3-vs-Stage4
2.732200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.574300E-02
Normal-vs-AfricanAmerican
1.815840E-01
Normal-vs-Asian
1.011180E-01
Caucasian-vs-AfricanAmerican
7.731200E-01
Caucasian-vs-Asian
4.745600E-01
AfricanAmerican-vs-Asian
8.217600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.524000E-02
Normal-vs-Female
7.825800E-02
Male-vs-Female
6.788200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.425450E-01
Normal-vs-Age(41-60Yrs)
4.240200E-01
Normal-vs-Age(61-80Yrs)
1.301230E-01
Normal-vs-Age(81-100Yrs)
2.943200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.108400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.665800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.046200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.404800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.592500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.465640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.071200E-01
Normal-vs-Daily Drinker
4.082400E-02
Normal-vs-Weekly Drinker
3.331200E-01
Normal-vs-Occasional Drinker
5.127400E-01
Normal-vs-Social Drinker
1.025230E-01
Non Drinker-vs-Daily Drinker
3.607600E-01
Non Drinker-vs-Weekly Drinker
7.521400E-01
Non Drinker-vs-Occasional Drinker
3.151200E-01
Non Drinker-vs-Social Drinker
9.806400E-01
Daily Drinker-vs-Weekly Drinker
2.607800E-01
Daily Drinker-vs-Occasional Drinker
3.058200E-02
Daily Drinker-vs-Social Drinker
2.988600E-01
Weekly Drinker-vs-Occasional Drinker
6.916800E-01
Weekly Drinker-vs-Social Drinker
7.599400E-01
Occasional Drinker-vs-Social Drinker
2.816200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.013800E-01
Normal-vs-Grade 2
5.090200E-02
Normal-vs-Grade 3
5.885700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.435100E-04
Grade 1-vs-Grade 3
4.837500E-03
Grade 1-vs-Grade 4
4.013800E-01
Grade 2-vs-Grade 3
4.768800E-01
Grade 2-vs-Grade 4
5.090200E-02
Grade 3-vs-Grade 4
5.885700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.424010E-01
Normal-vs-NonDiabetic
6.772400E-02
Diabetic-vs-NonDiabetic
4.339400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.361780E-01
Normal-vs-NoPancreatitis
9.208300E-02
Pancreatitis-vs-NoPancreatitis
8.777200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.127800E-02
Normal-vs-N1
1.001410E-01
N0-vs-N1
6.125200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.446630E-01
Normal-vs-TP53-NonMutant
4.546300E-02
TP53-Mutant-vs-TP53-NonMutant
5.356400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
